Why Wegovy vs Mounjaro Side Effects Matter for Your Choice
Wegovy Side Effects vs Mounjaro: Understanding the Key Differences
When comparing Wegovy side effects vs Mounjaro, the fundamental difference lies in their receptor targets and resulting side effect profiles. Wegovy (semaglutide) selectively activates GLP-1 receptors, typically causing gastrointestinal side effects including nausea, vomiting, diarrhoea, and constipation in clinical trials. These effects generally appear during dose escalation phases and may diminish as your body adapts to the medication. Mounjaro (tirzepatide) targets both GIP and GLP-1 receptors simultaneously, which can produce similar gastrointestinal effects but potentially with different intensity patterns due to its dual mechanism.
The side effect timeline often differs between these treatments when evaluating Wegovy side effects vs Mounjaro experiences. Wegovy's graduated dosing schedule from 0.25mg to 2.4mg over 16 weeks is specifically designed to minimise side effects through careful titration. Mounjaro follows its own escalation pattern from 2.5mg to 15mg maximum dose, with each treatment requiring individual assessment. Both medications list injection site reactions, fatigue, and potential gallbladder issues as possible side effects, though individual responses vary significantly. Your prescriber can help determine which side effect profile may be more suitable for your lifestyle and medical history.
Wegovy vs Mounjaro Pricing: Complete Cost Comparison
Understanding the cost difference in Wegovy side effects vs Mounjaro treatment requires examining our complete pricing structure for both options. Wegovy single pens range from £79.99 for the 0.25mg starter dose to £209.99 for the 2.4mg maintenance strength, with convenient bundles like our Intro Duo (0.25mg & 0.5mg) at £169.99. Our Gentle Start Trio provides extended low-dose treatment (0.25mg, 0.25mg, 0.5mg) for £269.99, perfect for those concerned about side effects. New customers receive code FIRST40 whilst returning customers use DOSE25, both applied at checkout to reach these final prices.
When comparing Wegovy side effects vs Mounjaro costs, both treatments represent significant investments in your health journey. Mounjaro pricing follows its own structure based on different dose strengths and titration schedule, with both medications requiring ongoing commitment for sustained results. Our Ultimate Stability Trio (three 2.4mg Wegovy pens) provides three months of maintenance supply for £649.99, ensuring treatment continuity without frequent reordering. The convenience of bundled options reduces delivery frequency whilst guaranteeing supply, particularly important when managing potential side effects during dose transitions.
Clinical Evidence: Wegovy Side Effects vs Mounjaro Trial Data
Clinical trial data provides crucial insights when evaluating Wegovy side effects vs Mounjaro safety profiles. The STEP programme demonstrated that Wegovy's most common side effects included nausea (44% vs 9% placebo), diarrhoea (30% vs 16% placebo), and vomiting (24% vs 6% placebo) according to Wilding et al., NEJM, 2021. Most participants experienced these effects during dose escalation phases, with many reporting improvement over time as their bodies adapted to treatment.
Mounjaro's SURMOUNT trials revealed similar gastrointestinal side effect patterns, though direct head-to-head comparison isn't appropriate due to different trial designs and patient populations. Both treatments showed that side effects were generally dose-dependent and more common during titration phases rather than maintenance periods. Individual responses vary considerably, making personal medical assessment essential when choosing between these options.
How Wegovy Works: GLP-1 Mechanism Explained
Understanding Wegovy's mechanism helps explain its side effect profile when comparing Wegovy side effects vs Mounjaro responses. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormones responsible for blood sugar regulation and appetite control. This medication works primarily in your brain's appetite centres, reducing hunger signals whilst simultaneously slowing gastric emptying to promote earlier satiety after meals. The delayed stomach emptying explains why nausea and digestive side effects are common, particularly during initial treatment phases. Wegovy also influences reward pathways in the brain, potentially reducing food cravings and emotional eating patterns that contribute to weight gain. This comprehensive approach to appetite regulation requires careful dose escalation to minimise side effects whilst maximising therapeutic benefits.
EverydayMeds Ordering Process: Simple Assessment to Delivery
Getting started with either treatment when considering Wegovy side effects vs Mounjaro options involves our streamlined three-step process designed for convenience and safety. Begin with our 3-minute online clinical assessment covering your medical history, current medications, and weight management goals, allowing our prescribers to evaluate which treatment might suit your individual circumstances. Your assessment undergoes thorough review by our qualified prescribers within standard 3 working days, or express 24-hour service for urgent requirements. Once approved, your medication dispatches via next-day delivery using specialist cold-chain transport to maintain temperature integrity from our GPhC-registered pharmacy directly to your door. Our process ensures you receive authentic medication with proper storage throughout transit, crucial for maintaining both treatments' effectiveness and safety. Each delivery includes comprehensive information about potential side effects, proper injection technique, and dose escalation schedules specific to your prescribed treatment.
Storage Advantages: Wegovy vs Mounjaro Practical Differences
Storage requirements present a practical consideration when evaluating Wegovy side effects vs Mounjaro convenience factors. Wegovy offers superior travel flexibility with 6 weeks room temperature storage below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require initial refrigerated storage between 2-8°C before first use, but Wegovy's extended room temperature tolerance makes it more suitable for extended travel, business trips, or situations where refrigeration access might be limited. The FlexTouch pen design provides easy injection with dose confirmation, whilst proper storage maintains medication potency throughout your treatment cycle. This storage advantage can reduce anxiety about medication management, potentially improving treatment adherence and outcomes. Always follow specific storage instructions provided with your medication, as improper storage can affect both effectiveness and safety profiles.
Wegovy Side Effects vs Mounjaro: Individual Response Patterns
Personal response variation makes direct comparison of Wegovy side effects vs Mounjaro experiences highly individual, requiring personalised medical assessment rather than generalised assumptions. Some patients report better tolerance with Wegovy's GLP-1-only mechanism, whilst others find Mounjaro's dual GIP/GLP-1 approach more suitable for their physiology. Factors influencing individual responses include baseline metabolic health, concurrent medications, eating patterns, and genetic variations in drug metabolism that cannot be predicted without clinical evaluation. Your medical history, particularly regarding gastrointestinal conditions, diabetes status, and previous weight management attempts, influences which treatment your prescriber might recommend.
The timing and intensity of side effects often differ between individuals, making patient monitoring crucial regardless of which treatment you choose. Both medications require commitment to dietary modifications and increased physical activity alongside injection therapy, which can influence side effect experiences. Some patients find that gradual lifestyle changes parallel to medication titration helps minimise gastrointestinal effects, whilst others require more structured support during initial treatment phases. Regular communication with healthcare providers ensures optimal dose adjustment and side effect management throughout your weight management journey.
Start Your Weight Management Journey: Both Treatments Available
Both Wegovy and Mounjaro are available from EverydayMeds, ensuring you can access whichever treatment your prescriber determines most appropriate for your individual circumstances and side effect concerns. Our clinical team evaluates each assessment thoroughly, considering your medical history, current health status, and treatment goals when making prescribing recommendations. Use discount code FIRST40 for new customers or DOSE25 for returning patients, applied automatically at checkout to reach our advertised prices starting from £79.99. Begin your assessment today at https://everydaymeds.co.uk/collections/weight-loss to explore which prescription-only medicine might support your weight management goals most effectively. Our registered pharmacy (GPhC #9012878) ensures authentic medication supply with professional oversight throughout your treatment journey, providing the medical support necessary for successful long-term weight management alongside a reduced-calorie diet and increased physical activity.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
